1. Home
  2. IDT vs ANAB Comparison

IDT vs ANAB Comparison

Compare IDT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

N/A

Current Price

$77.30

Market Cap

1.5B

ML Signal

N/A

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$45.48

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDT
ANAB
Founded
1990
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
IDT
ANAB
Price
$77.30
$45.48
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $87.25
AVG Volume (30 Days)
128.6K
★ 371.5K
Earning Date
12-03-2026
11-12-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
14.95
★ 91.02
EPS
★ 3.46
0.11
Revenue
★ $1,231,495,000.00
$234,603,000.00
Revenue This Year
$2.39
$28.82
Revenue Next Year
$0.75
$24.35
P/E Ratio
★ $22.47
$414.64
Revenue Growth
2.13
★ 157.01
52 Week Low
$46.48
$33.10
52 Week High
$84.56
$73.30

Technical Indicators

Market Signals
Indicator
IDT
ANAB
Relative Strength Index (RSI) 38.45 40.38
Support Level $51.16 $44.25
Resistance Level $84.48 $57.55
Average True Range (ATR) 2.14 1.70
MACD -0.86 -0.11
Stochastic Oscillator 14.00 18.60

Price Performance

Historical Comparison
IDT
ANAB

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: